drugset / Trial / NCT03916393
PF-06651600 Taste Study.
RandomizedCrossoverSingle-blindBasic science
Summary
This is a single-blind, randomized, five (5)-period, cross-over study in healthy adult participants. A group of approximately 10 participants will assess the sensory attributes (taste and palatability) of 4 different formulations of an investigational product (PF-06651600 active pharmaceutical ingredient) and Bitrex (Registered) positive control in a specified sequence in 1 day.
Timeline
- Start
- 2019-04-15
- Primary completion
- 2019-05-10
- Completion
- 2019-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritlecitinib | Small molecule | 20 mg | Oral |
Indications
No indication recorded.